TYRA insider buying and SEC filings, explained
Tyra Biosciences, Inc. · CIK 1863127
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$20K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$10.1M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 15, 2026 | Other purchase | Peter Kolchinsky (Director and 10% owner) bought 9,078,529 Pre-Funded Warrants (Right to Buy) indirectly at $22.03 ($200.0M), reported as a purchase (code P). Indirect holdings up 358% to 11,616,986 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Sep 17, 2026 |
| Sep 9, 2026 | Purchase (code P) | Rehan Verjee (Director) bought 972 shares at about $20.58 ($20K), reported as a purchase (code P). New position of 972 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| Feb 12, 2026 | Planned (10b5-1) | Daniel Bensen (Chief Discovery Officer) sold 8,000 shares at about $32.87 ($263K), marked as a 10b5-1 plan trade. Holdings down 5% to 146,981 shares. | SEC filing Filed Feb 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Daniel Bensen (Chief Discovery Officer) sold 8,000 shares at about $28.52 ($228K), marked as a 10b5-1 plan trade. Holdings down 5% to 154,981 shares. | SEC filing Filed Jan 20, 2026 |
| Dec 19, 2025 | Planned (10b5-1) | Robert J. More (Director) sold 10,000 shares indirectly at $25.00 ($250K), marked as a 10b5-1 plan trade. Indirect holdings down <1% to 3,823,425 shares. | SEC filing Filed Dec 19, 2025 |
| Dec 12, 2025 | Planned (10b5-1) | Daniel Bensen (Chief Discovery Officer) sold 8,000 shares at about $22.64 ($181K), marked as a 10b5-1 plan trade. Holdings down 5% to 162,981 shares. | SEC filing Filed Dec 16, 2025 |
| Nov 21, 2025 | Planned (10b5-1) | Robert J. More (Director) sold 246,871 shares indirectly at about $20.25 ($5.0M), marked as a 10b5-1 plan trade. Indirect holdings down 6% to 3,833,425 shares. | SEC filing Filed Nov 25, 2025 |
| Nov 18–19, 2025 | Planned (10b5-1) | Daniel Bensen (President / COO) sold 125,589 shares between Nov 18, 2025 and Nov 19, 2025 at about $16.17 ($2.0M), marked as a 10b5-1 plan trade. Holdings down 42% to 170,981 shares. | SEC filing Filed Nov 19, 2025 |
| Nov 13–17, 2025 | Planned (10b5-1) | Daniel Bensen (President / COO) sold 131,411 shares between Nov 13, 2025 and Nov 17, 2025 at about $16.04 ($2.1M), marked as a 10b5-1 plan trade. Holdings down 31% to 296,570 shares. | SEC filing Filed Nov 17, 2025 |
21 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TYRA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.